Insider · CIK 0001219121

AUSTIN STEPHEN G

Reports to the SEC for 2 companies · ALISO VIEJO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001219121

Forms 4 and 5

Insider transactions

18 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-03-16	HROWHARROW, INC. · RSUM Exercise/Conversion	Director	MExercise/Conversion	−12.7K sh	—	—	59,529
2020-03-16	HROWHARROW, INC.M Exercise/Conversion	Director	MExercise/Conversion	+72.2K sh	—	—	91,987
2020-03-16	HROWHARROW, INC. · RSUM Exercise/Conversion	Director	MExercise/Conversion	−9,715 sh	—	—	0
2020-03-16	HROWHARROW, INC. · RSUM Exercise/Conversion	Director	MExercise/Conversion	−34.1K sh	—	—	9,715
2020-03-16	HROWHARROW, INC. · RSUM Exercise/Conversion	Director	MExercise/Conversion	−15.7K sh	—	—	43,806
2019-06-26	HROWHARROW, INC. · RSUA Award	Director	AAward	+9,715 sh	—	—	9,715
2018-06-29	HROWHARROW, INC. · RSUA Award	Director	AAward	+34.1K sh	—	—	34,091
2017-06-13	HROWHARROW, INC. · RSUA Award	Director	AAward	+15.7K sh	—	—	15,723
2016-06-10	HROWHARROW, INC. · RSUA Award	Director	AAward	+12.7K sh	—	—	12,690
2015-05-13	HROWHARROW, INC.A Award	Director	AAward	+6,281 sh	—	—	19,769
2014-09-04	HROWHARROW, INC.A Award	Director	AAward	+6,623 sh	—	—	13,488
2013-06-27	HROWHARROW, INC.A Award	Director	AAward	+6,865 sh	—	—	6,865
2012-07-26	HROWHARROW, INC. · Option - Right to BuyA Award	Director	AAward	+85.6K sh	—	—	85,616
2012-02-16	AVANIR PHARMACEUTICALS, INC.A Award	Director	AAward	+30K sh	—	—	270,094
2011-02-08	AVANIR PHARMACEUTICALS, INC.A Award	Director	AAward	+30K sh	—	—	240,094
2010-02-18	AVANIR PHARMACEUTICALS, INC.A Award	Director	AAward	+40K sh	—	—	210,094
2009-02-19	AVANIR PHARMACEUTICALS, INC.A Award	Director	AAward	+60K sh	—	—	170,094
2004-04-06	AVANIR PHARMACEUTICALS, INC.Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+5,000 sh	—	—	5,000

Recent filings

Accepted (ET)
Mar 184
AUSTIN STEPHEN G0001493152-20-004287
SEC(opens sec.gov)
Jun 284
AUSTIN STEPHEN G0001493152-19-009923
SEC(opens sec.gov)
Jul 24
AUSTIN STEPHEN G0001493152-18-009606
SEC(opens sec.gov)
Jun 154
Imprimis Pharmaceuticals, Inc.0001493152-17-006713
SEC(opens sec.gov)
Jun 144
Imprimis Pharmaceuticals, Inc.0001493152-16-010818
SEC(opens sec.gov)
May 154
Imprimis Pharmaceuticals, Inc.0001493152-15-002051
SEC(opens sec.gov)
Sep 84
Imprimis Pharmaceuticals, Inc.0001493152-14-002901
SEC(opens sec.gov)
Jul 14
Imprimis Pharmaceuticals, Inc.0001078782-13-001290
SEC(opens sec.gov)
Aug 154
AUSTIN STEPHEN G0001078782-12-002083
SEC(opens sec.gov)
Feb 174
AUSTIN STEPHEN G0001209191-12-011304
SEC(opens sec.gov)
Feb 104
AUSTIN STEPHEN G0001209191-11-008505
SEC(opens sec.gov)
Feb 224
AUSTIN STEPHEN G0001209191-10-011074
SEC(opens sec.gov)
Feb 204
AUSTIN STEPHEN G0001209191-09-010830
SEC(opens sec.gov)
Apr 84
AVANIR PHARMACEUTICALS0001186120-04-000031
SEC(opens sec.gov)

Companies

Address

101 ENTERPRISE, SUITE 300

ALISO VIEJO, CA, 92656